A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): Reversal of disease by bone marrow transplantation

Blood

Volumn 88, Issue 2, 1996, Pages 402-409

  Yan, Xiao Qiang ^b   Lacey, Dave ^b   Hill, Dave ^b   Chen, Ying ^b   Fletcher, Frederick ^b   Hawley, Robert G ^b   McNiece, Ian K ^a  

^a AMGEN INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL TRANSPLANTATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENE TRANSFER; LIGAND BINDING; MEGAKARYOCYTE; MOUSE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; OSTEOSCLEROSIS; PRIORITY JOURNAL; STROMA CELL;

EID: 0029956149     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.2.402.bloodjournal882402     Document Type: Article

References (27)

1. Hasselbalch HC: Idiopathic myelofibrosis - An update with particular reference to clinical aspects and prognosis. Int J Clin Lab Res 23:124, 1993
2. Weinstein IM: Idiopathic myelofibrosis: Historical review, diagnosis and management. Blood Rev 5:98, 1991
3. Reilly JT: Pathogenesis of idiopathic myelofibrosis: Role of growth factors. J Clin Pathol 45:461, 1992
4. Reilly JT: Pathogenesis of idiopathic myelofibrosis: Present status and future directions. Br J Haematol 88:1, 1994
5. Groopman JE: The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann Intern Med 92:857, 1980
6. Gilbert HS: Myelofibrosis revisited: Characterization and classification of myelofibrosis in the setting of myeloproliferative disease, in Berk PD, Castro-Malaspina H, Wasserman LR (eds): Myelofibrosis and the Biology of Connective Tissue. New York, NY, Liss, 1984, p 3
7. Terui T, Niitsu Y, Mahara K, Fujisaki Y, Urushizaki Y, Mogi Y, Kohgo Y, Watanabe N, Ogura M, Saito H: The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood 75:1540, 1990
8. Heldin CH: Structural and functional studies on platelet-derived growth factor. EMBO J 11:4251, 1992
9. Ross R, Raines EW, Bowen-Pope DF: The biology of plateletderived growth factor. Cell 46:155, 1986
10. Roberts AB, Sporn MB: Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8:1, 1993
11. Kingsley DM: The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133, 1994
12. Buhr T, Choritz H, Georgii A: The impact of megakaryocyte proliferation of the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia. Anat Histopathol 420:473, 1992
13. Thiele J, Hoeppner B, Zankovich R, Fischer R: Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia) - Correlations between clinical and morphological features. Anat Histopathol 415:191, 1989
14. Johnston JB, Dalal BI, Israels SJ, Oh S, McMillan E, Gegleiter A, Michaud G, Israels LG, Greenberg AH: Deposition of transforming growth factor-β in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-β by leukemic cells. Am J Pathol 103:574, 1995
15. Rameshwar P, Denny TN, Stein D, Gascon P: Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-beta. J Immunol 153:2819, 1994
16. Yan XQ, Lacey D, Fletcher F, Hartley C, McElroy P, Sun Y, Xia M, Mu S, Saris C, Hill D, Hawley RG, McNiece IK: Chronic exposure to retroviral vector encoded TPO (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 86:4025, 1995
17. Hibbin JA, Njoku OS, Matutes E, Lewis SM, Goldman JM: Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br J Haematol 57:495, 1984
18. Hawley RG, Fong AZC, Burns BF, Hawley TS: Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med 176:1149, 1992
19. Markowitz D, Goff S, Bank A: A safe packaging line for gene transfer: Separating vial genes on two different plasmids. J Virol 62:1120, 1988
20. Iscove NN: Culture of lymphocytes and hemopoietic cells in serum-free medium, in Barnes D, Sirbascu D, Sato G (eds): Methods for Serum-Free Culture of Neuronal and Lymphoid Cells. New York, NY, Liss, 1984, p 169
21. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
22. Bancroft JD, Stevens A: Theory and Practice of Histological Techniques. New York, NY, Churchill Livingstone, 1990
23. Creemers GJ, Lowenberg B, Hagenbeek A: Allogeneic bone marrow transplantation for primary myelofibrosis. Br J Haematol 82:772, 1992
24. Dokal I, Jones L, Deenmamode M, Lewis SM, Goldman JM: Allogeneic bone marrow transplantation for primary myelofibrosis. Br J Haematol 71:158, 1989
25. Noda M, Camilliere JJ: In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology 124:2991, 1989
26. Marcelli C, Yates AJ, Mundy GR: In vivo effects of human recombinant transforming growth factor-β on bone turnover in normal mice. J Bone Miner Res 5:1087, 1990
27. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annuniziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693, 1992